P349 Introduction: We present two patients that developed sarcoid-like reactions after
initiation of immunotherapy. The first patient presented with clear cell endometrial cancer …

DISCUSSION: The differential diagnosis for pulmonary granulomatous disease includes non-
infectious etiologies such as sarcoidosis or hypersensitivity pneumonitis, infectious …

Immune checkpoint inhibitors (ICIs) have become the standard of care for the treatment of
non‐small cell lung cancer (NSCLC). With the increasing use of ICIs, clinicians should be …

Immune checkpoint inhibitors are associated with a wide spectrum of immune-related
adverse events (AE) of different severity. Immune-related sarcoidosis-like reactions are …

Background The use of immune checkpoint inhibitors (ICI) has revealed a new panel of
tumor response and adverse events. Immune-related sarcoidosis-like reactions is frequently …

Clinically useful high-quality radiologic depiction relevant to radiologists' practice. Treatment-
induced sarcoid-like reactions, due to T-cell mediated non-caseating granuloma formation …

The use of immune checkpoint inhibitors has dramatically improved outcomes for patients
with advanced melanoma and other malignancies. Checkpoint inhibitors are associated with …

We congratulate Wang et al.[1] on their timely and informative review of the use of immune
checkpoint inhibitors in the treatment of lung cancer. Their review is critical reading for all …

Nowadays, immune checkpoint inhibitors (ICI) have become the cornerstone of treatment for
many tumors, either as monotherapy or in combination with other therapies. However, these …

The toxicity profile of pembrolizumab is mostly defined by immune-related adverse events
affecting pulmonary, skin, gastrointestinal and endocrine tracts [1, 2]. We report here the first …